Markus Schick - AstrZeneca | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 3627: Volrustomig a novel PD-1/CTLA-4 bispecific antibody leads to robust increase in peripheral and intra-tumoral pharmacodynamic biomarkers in solid tumors from FTiH study

Ikbel Achour,Michael Kuziora, Florian Song, Steven Eck,Lina Meinecke,Jorge Blando, Jennifer Pearson,Megha Saraiya, Christian Eisen,Felix Segerer,Markus Schick, Nicolas Triltsch,

Cancer Researchno. 6_Supplement (2024): 3627-3627

引用0浏览0引用

An unsupervised workflow for explainable biomarker identification based on multiplex data

Tillmann Falck,Harald Hessel, Florian Song,Markus Schick, Corina Cotoi,Nicolas Brieu

Medical Imaging 2024: Digital and Computational Pathology (2024)

引用0浏览0引用

Abstract 2492: Enhanced patient selection for anti-PD-L1 treatment in metastatic NSCLC with quantitative continuous scoring of PD-L1

Jan Martin Lesniak,Markus Schick, Thomas Kunzke, Federico Pollastri, Juan Pedro Vigueras-Guillén,Harald Hessel,Susanne Haneder, Pallavi Sontakke,Karma DaCosta, Regina Alleze,Hadassah Sade,J Carl Barrett,

Cancer Researchno. 6_Supplement (2024): 2492-2492

引用0浏览0引用

Abstract 2023: Multiplex immunofluorescence profiling of the tumor microenvironment and CD73: Activity of neoadjuvant oleclumab in patients with non-small-cell lung cancer in NeoCOAST

Ina Bisha,Tze Heng Tan, Manuela Weitkunat,Alma Andoni, Iris Dino,Philip Martin,Megha Saraiya,Karma DaCosta, Pallavi Sontakke,Markus Schick,Michael Surace,Jorge Blando,

Cancer Researchno. 6_Supplement (2024): 2023-2023

引用0浏览0引用

Abstract PO4-26-01: Computational pathology: Revolutionizing diagnostics and clearing the way for precision medicine

Mark Gustavson,Markus Schick, Ansh Kapil,Anatoliy Shumilov, Carl Barrett,Hadassah Sade

Cancer Researchno. 9_Supplement (2024): PO4-26

引用0浏览0引用

ReStainGAN: Leveraging IHC to IF Stain Domain Translation for in-silico Data Generation

Dominik Winter,Nicolas Triltsch, Philipp Plewa, Marco Rosati, Thomas Padel, Ross Hill,Markus Schick,Nicolas Brieu

CoRR (2024)

引用0浏览0EI引用

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer

Ansh Kapil, Andreas Spitzmüller,Nicolas Brieu, Susanne Haneder,Anatoliy Shumilov,Armin Meier,Fabiola Cecchi, Alice Barkell,Nathalie Harder, Katrin Mittermaier,Ana Hidalgo-Sastre, Regina Alleze,

Scientific reportsno. 1 (2024): 12129-12129

引用0浏览0WOSNATURE引用

1505 Spatial profiling of the SCLC tumor microenvironment defined by high MHC-I expression reveals association with functionally relevant antigen presentation

Guenter Schmidt, Nicolas Brieu,Harald Hessel, Andreas Spitzmüller,Jaime Rodriguez Canales,Helen Angell,Markus Schick,Mingchao Xie,Mari Heininen-Brown, Miljenka Vuko, Monica Azqueta Gavaldon,Felix Segerer,

Journal for ImmunoTherapy of Cancer（2023）

引用0浏览0引用

Computational Pathology-Based Assessment of cMET IHC Expression for Patient Selection in the Treatment of MET Overexpressing NSCLC

S. Christ,A. Kapil, I. Bisha, J. Chan, A. Andoni, C. Cotoi,M. Schick,G. Schmidt, R. Hartmaier, H. Sade

Journal of Thoracic Oncologyno. 11 (2023): S497-S497

引用0浏览0引用

605 Computational pathology-based digital twins enable the discovery of predictive biomarkers for precision immuno-oncology

Ross Stewart,Johannes Zimmermann,Guenter Schmidt,Markus Schick,Jan Lesniak, Thomas Kunzke, Federico Pollastri

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn